The effect of vitamin D on hyperandrogenism and metabolism in patients with PCOS

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100042326

Enrollment

Unknown

Registered

2021-01-19

Start date

2021-01-19

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Group 1:Vitamin D 4000IU

Group 2:vitamin D 2000IU

Control Group:placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Aged 18-40 years. 2.The diagnosed criteria of PCOS: Oligo-oranovulation, irregular bleeding;clinical or biomedical hyperandrogenism; PCOM diagnosed by ultrasound;excluding other factors which could result in hyperandrogenism. 3.BMI:25-29.9kg/m2. 4.The level of vitamin D <30ng/ml. 5.Normal hepatic function and renal function. 6.The intake dose vitamin D from diet is less than 600IU/d. 7.Normal blood routine. 8.Assign informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation; 2.Medical disesae; 3.Drug taking or alcohol addiction; 4.Smoking; 5.Abnormal hepatic or renal function.

Design outcomes

Primary

Measure	Time frame
the serum androgen;SHBG;insulin releasing test;HOMA-IR;	—

Countries

China

Contacts

Public ContactXiaocui Song

The Second Hospital, Cheeloo College of Medicine, Shandong University

babyjuncong@163.com+86 17660081578

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026